Picture of CellaVision AB logo

CEVI — CellaVision AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Brief: CellaVision Q2 EBITDA SEK 56 Million

Jul 20 (Reuters) - CellaVision Q2 adjusted EPS SEK 1.46.
* Q2 sales SEK 170 million
* Q2 EBITDA margin 33%
* Q2 pretax profit SEK 44 million

Recent news on CellaVision AB

See all news